UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Shire’s SBS treatment to bring new hope to pediatric patients
Gattex (ingredient name: Teduglutide), Shire’s short bowel syndrome (SBS) t...
by Lee Han-soo
|
2018-09-11 16:17
라인
Hepatitis C patients wait for Maviret’s arrival
Korean physicians and patients have expressed high expectations for AbbVie ...
by Nam Doo-hyun
|
2018-09-11 16:16
라인
Medpecto to test immunotherapy combo with MSD
Medpacto, a subsidiary of Theragen ETEX, said Tuesday that the Ministry of ...
by Lee Han-soo
|
2018-09-11 13:04
라인
Astellas wins nod for phase-3 trial on gastric cancer treatment
Astellas has obtained the regulatory approval to go ahead with a global pha...
by Lee Hye-seon
|
2018-09-11 10:38
라인
MERS infection affects stock market
Pharmaceuticals and biotech businesses are gathering renewed attention afte...
by So Jae-hyeon
|
2018-09-10 16:25
라인
Kwangdong licenses Canadian company’s nonsteroidal anti-inflammatory drug candidate
Kwangdong Pharmaceutical said Monday that it has signed a licensing agreeme...
by Lee Han-soo
|
2018-09-10 14:23
라인
Pfizer Korea ordered to suspend imports of 3 drugs for poor quality control
The government has ordered Pfizer Korea to halt imports of three drugs for ...
by Lee Hye-seon
|
2018-09-07 16:24
라인
Biopharmaceuticals lead Korea’s drug output growth
Korea’s pharmaceutical output has exceeded 20 trillion won ($17.8 billion) ...
by Lee Hye-seon
|
2018-09-07 13:47
라인
Antihypertensive drug Kanarb tops output among local new drugs
Boryung Pharmaceutical’s antihypertensive treatment Kanarb marked the large...
by Lee Hye-seon
|
2018-09-07 11:08
라인
Opdivo-Yervoy okayed as first-line treatment for renal cell carcinoma
The Korean government has approved Ono Pharma Korea and Bristol-Myers Squib...
by Nam Doo-hyun
|
2018-09-06 15:02
라인
Spectrum announces new clinical trial results for Hanmi's lung cancer drug
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Tuesday that it present...
by Lee Han-soo
|
2018-09-06 14:34
라인
Antidiabetic combo Steglujan approved in Korea
MSD Korea said it has won approval to sell an antidiabetic combination drug...
by Lee Hye-seon
|
2018-09-06 11:55
라인
Hugel to set up US offshoot
Hugel said Wednesday that it plans to establish a subsidiary in the United ...
by Lee Han-soo
|
2018-09-06 11:55
라인
Seoul decides to reimburse Janssen’s plaque psoriasis treatment
Janssen, a subsidiary of Johnson and Johnson, said Wednesday the Ministry o...
by Lee Han-soo
|
2018-09-05 17:59
라인
Hanmi unveils research results for Rosuzet and Amosartan Plus
Hanmi Pharmaceutical has presented research results on Rosuzet and Amosarta...
by Lee Han-soo
|
2018-09-05 16:14
라인
Pfizer seeks Yuhan’s help to keep anti-smoking drug rolling
Pfizer has picked Yuhan Corp. as a partner to defense its smoking cessation...
by So Jae-hyeon
|
2018-09-05 11:59
라인
JW, Aekyung to co-develop derma cosmetics products
JW Shinyak, a subsidiary of JW Holdings, said Tuesday that it has signed a ...
by Lee Han-soo
|
2018-09-04 13:24
라인
CrystalGenomics to export novel drug Acelex to Brazil soon
Acelex, the nation’s 22nd novel drug treating degenerative arthritis, is so...
by Nam Doo-hyun
|
2018-09-04 11:18
라인
Handok names new CEO
Handok has appointed Cho Jeong-yol as its new president and CEO. ...
by Lee Han-soo
|
2018-09-04 11:13
라인
Sillajen reports 1st patient enrollment for Pexa-Vec’s Chinese P3 trials
Sillajen announced Monday that the company has enrolled its first patient f...
by Lee Han-soo
|
2018-09-03 17:59
-
이전
71
72
73
74
75
76
77
78
79
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top